Azenta to participate in the Stephens Annual Investment Conference
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the Stephens Annual Investment Conference in Nashville, Tennessee on November 16, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the Stephens Annual Investment Conference in Nashville, Tennessee on November 16, 2022. The presentation will start at 12:00 pm CT and can be accessed via a live webcast on Azenta's investor relations website. A replay will also be available post-event. Azenta provides comprehensive life sciences solutions, including cold-chain sample management and genomic services, supporting pharmaceutical and biotech sectors globally. For more details, visit Azenta's website.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was -2.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., Nov. 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee, on Wednesday, November 16, 2022, which includes a presentation beginning at 12:00 pm CT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations
978.262.2635
ir@azenta.com
Sherry Dinsmore
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-stephens-annual-investment-conference-301672615.html
SOURCE Azenta, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.